Frontiers in Cardiovascular Medicine | Lipids in Cardiovascular Disease

Opinion

Published on 01 Jul 2025

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?

in Lipids in Cardiovascular Disease

Alpo Vuorio
Frederick J. Raal
Petri T. Kovanen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1624049

1,060 views

Original Research

Published on 30 Jun 2025

Non-high-density lipoprotein cholesterol predicts cardiovascular risk better than remnant cholesterol in patients with type 2 diabetes mellitus

in Lipids in Cardiovascular Disease

Paul Nsiah
Samuel Acquah
Ansumana Sandy Bockarie
George Adjei
Ebenezer Aniakwaa-Bonsu
Oksana Ryabinina

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1551203

504 views

Original Research

Accepted on 27 Jun 2025

Association between fasting glucose/high-density lipoprotein cholesterol ratio and cardiovascular disease risk in Chinese middle-aged and older adults: a longitudinal study

in Lipids in Cardiovascular Disease

Jintao Chen
Liying Yan
Jianhai Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1609891

204 views

Original Research

Published on 19 Jun 2025

Relationship between dynamic changes in remnant cholesterol and cardiovascular disease in middle-aged and older Chinese: a national cohort study

in Lipids in Cardiovascular Disease

Bin Zhang
Dengfeng Ma
Zhiqiang Pei
Qian Ren
Jin Qiu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1503705

610 views

Mini Review

Accepted on 18 Jun 2025

Reverse Cholesterol Transport: Current assay methods, alterations with disease and response to therapeutic intervention

in Lipids in Cardiovascular Disease

Martin Playford
Edward B Neufeld
Rafael Zubiran
Alan T Remaley

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1608384

213 views

Original Research

Accepted on 16 Jun 2025

Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: Insights from the Moli-sani cohort study

in Lipids in Cardiovascular Disease

Francesco Gianfagna
Simone Poli
Simona Costanzo
Augusto Di Castelnuovo
Teresa Panzera
Amalia De Curtis
Sara Magnacca
Mariarosaria Persichillo
Lorenzo De Santi
Claudia Cristofani

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1571395

301 views

Systematic Review

Published on 11 Jun 2025

Global scientific trends in hypercholesterolemia research from 2003 to 2023: a data-driven bibliometric and visual analysis

in Lipids in Cardiovascular Disease

Haoxin Guo
Qihui Wang
Yinling Wang
Xiaolong Dong
Zhongqing Wang
Hui Kang
Shitong Cheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1524697

1,042 views

Original Research

Published on 09 Jun 2025

Lipid accumulation product index is inversely U-shaped associated with abdominal aortic calcification based on NHANES 2013–2014

in Lipids in Cardiovascular Disease

Jiangbei Deng
Xiao Qin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1524847

988 views

Case Report

Published on 09 Jun 2025

Familial hypercholesterolaemia with early-onset coronary artery disease and recurrent in-stent restenosis associated with the LDLR gene c.428G>A mutation: a case report

in Lipids in Cardiovascular Disease

Chengpeng Zhang
Hui Li
Wei Zhang
Jian Huang
Jing Zhu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1573543

1,067 views

Editorial

Published on 29 May 2025

Editorial: Cardiovascular risk and lipoprotein(a): beyond LDL cholesterol

in Lipids in Cardiovascular Disease

Giuseppe Mandraffino
Laura D'Erasmo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1607395

961 views

Case Report

Published on 27 May 2025

Case Report: Practical approach to unmask unspecific adverse effects under lipid-lowering medication

in Lipids in Cardiovascular Disease

Thomas Büttner
Gunther Hartmann
Martin Coenen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1604129

909 views

Original Research

Published on 22 May 2025

Missing in action: the genetic mysteries of extremely low HDL cholesterol

in Lipids in Cardiovascular Disease

Shoshi Sphitzen
Mordechai Golomb
Mohammad Mowaswes
Refael Bitzur
Smadar Horowitz Cederboim
Ronen R. Leker
Marc Gotkine
Itai Chovers
Daniel Schurr
Eran Leitersdorf

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1553259

1,092 views

Original Research

Published on 13 May 2025

CTRP3 attenuates myocardial lipotoxicity via suppression of lipid accumulation, inflammation, apoptosis, and mitochondrial oxidative stress

in Lipids in Cardiovascular Disease

Qingpeng Wang
Jiangyang Chi
Chen Wang
Yanhong Yuan
Rui Tian
Yun Yang
Xinzhong Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1575929

967 views

Original Research

Published on 09 May 2025

Association of platelet-to-high-density lipoprotein cholesterol ratio and its cumulative exposure with cardiovascular disease risk: a prospective cohort study in Chinese population

in Lipids in Cardiovascular Disease

Honglian Luo
Gang Li
Yan Chen
Yun Shen
Wei Shen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1580359

1,678 views

Original Research

Published on 02 May 2025

Decrease in low-density lipoprotein cholesterol is associated with an increased risk of mortality in patients with diabetes mellitus

in Lipids in Cardiovascular Disease

Yun Gi Kim
Joo Hee Jeong
Kyung-Do Han
Seung-Young Roh
Chang-Ok Seo
Yeji Kim
Hyoung Seok Lee
Jaemin Shim
Young-Hoon Kim
Jong-Il Choi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1549517

1,591 views

Original Research

Published on 24 Apr 2025

Lipoproteins predicting coronary lesion complexity in premature coronary artery disease: a supervised machine learning approach

in Lipids in Cardiovascular Disease

Marta Marcinkowska
Agnieszka Kuchta
Petra Małgorzata Grešner
Tomasz Figatowski
Piotr Kasprzyk
Radosław Targoński
Wojciech Sobiczewski
Miłosz Jaguszewski
Marcin Fijałkowski
Marcin Gruchała

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1470500

1,415 views